InvestorsHub Logo
icon url

ronpopeil

02/14/11 7:45 PM

#114746 RE: mcbio #114743

Glad to be in the same stock with you. Just a reminder of the deal they have with SLXP which is a very impressive company:

"Salix Pharmaceuticals Ltd. said Monday that it will pay $60 million up front – and possibly hundreds of millions of dollars long term ­– to license a constipation drug named Relistor from Progenics Pharmaceuticals Inc.

In addition to the upfront payment, Morrisville-based Salix also could pay up to $90 million in U.S. development milestones, according to a written statement issued by the companies. In addition, Salix may pay sales-based milestones of as much as $200 million plus royalties from U.S. sales, as well as 60 percent of all revenue received from non-U.S. sublicensees.

Read more: Salix pays $60M to license Relistor from Progenics | Triangle Business Journal"




It's very impressive that SLXP would give so much to PGNX under this deal. PGNX has a market cap of around $150 million which is ridiculously low given this deal.

Btw, if you are looking for another bio play, i suggest AMRN. i like that one a lot too. Bought in around $5 and still holding
icon url

ronpopeil

02/14/11 9:12 PM

#114752 RE: mcbio #114743

also, the ceo seemed pretty excited to announce phase 1 prostate cancer results. hopefully something encouraging will be announced
icon url

JJM760

02/14/11 9:17 PM

#114753 RE: mcbio #114743

Come on now mcbio, you have been on the fence with Ariad for a while now. What do we have to do to close this deal? And how about you Dew? What would you say if I threw in a set of lovely steak knives? If you two jump in, it will make the Ariad board homers fall over themselves with joy!